|
NME7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.806500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.023300E-04 |
| Normal-vs-Stage2 |
3.761600E-01 |
| Normal-vs-Stage3 |
5.391600E-01 |
| Normal-vs-Stage4 |
5.407000E-01 |
| Stage1-vs-Stage2 |
2.334000E-01 |
| Stage1-vs-Stage3 |
2.816200E-04 |
| Stage1-vs-Stage4 |
3.284100E-02 |
| Stage2-vs-Stage3 |
1.922360E-01 |
| Stage2-vs-Stage4 |
6.580800E-01 |
| Stage3-vs-Stage4 |
2.953000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.644360E-02 |
| Normal-vs-AfricanAmerican |
8.053800E-01 |
| Normal-vs-Asian |
9.950600E-01 |
| Caucasian-vs-AfricanAmerican |
5.520000E-02 |
| Caucasian-vs-Asian |
5.865400E-01 |
| AfricanAmerican-vs-Asian |
9.280200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.808300E-02 |
| Normal-vs-Female |
3.458300E-02 |
| Male-vs-Female |
5.734800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.557400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.155900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.680300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.012600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.145600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.593600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.665800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.753600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.643600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.38160000004739E-06 |
| Normal-vs-Grade 2 |
2.203400E-04 |
| Normal-vs-Grade 3 |
1.775950E-01 |
| Normal-vs-Grade 4 |
6.250300E-02 |
| Grade 1-vs-Grade 2 |
1.096010E-01 |
| Grade 1-vs-Grade 3 |
1.421530E-02 |
| Grade 1-vs-Grade 4 |
2.221300E-04 |
| Grade 2-vs-Grade 3 |
1.997650E-02 |
| Grade 2-vs-Grade 4 |
4.62160000003209E-06 |
| Grade 3-vs-Grade 4 |
5.104800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.56969995177303E-09 |
| Normal-vs-ccB subtype |
2.658400E-02 |
| ccA subtype-vs-ccB subtype |
6.17284001691587E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.458400E-02 |
| Normal-vs-N1 |
8.086800E-01 |
| N0-vs-N1 |
3.449600E-01 |
|
|
